More from Aaron, at YMB, about the RTF:
"It's about to
More from Aaron, at YMB, about the RTF:
"It's about to get serious folks.
Here is looking a page eight from the RTF where the FDA reviewer describes all the data that Amarex failed to include.
Center page:
What is listed are the missing start and end dates of Adverse Events(AE) from the BLA.
Cursory glance shows one type of AE has ten incomplete start dates and five missing or incomplete end dates.
Another type of AE has 2 incomplete start dates and five missing or incomplete.
The third type of AE in that section has a whopping 45 missing start dates and 49 incomplete or missing end dates!
this isn't about science! This is a data collection service! They can't even collect start and end date information? Can you imagine any serious timeline critical data management service in any field that did that? (imagine if Pacer was missing start and end dates for trials and motion documents) Any Data Collection where not including dates would be considered acceptable?
Lower third of RTF page 8:
"However, the ADBL datasets do not include grading. Graded laboratory abnormalities are STANDARD and IMPORTANT."
We don't need to know the science behind ADBL datasets. What is important is that information about them is Missing and I highlighted the FDA reviewers stern rebuke when he says these are STANDARD and IMPORTANT!
Are we to believe the CEO of Amarex doesn't know "standard" and "important" data that must be collected?
But so far we are talking about egregiously not having information to collect! Can it get worse? YES!
How about the bottom most paragraph.
"... entries are present in CM.xpt but missing in ADCM..."
This is off the mark egregious! For this particular scientific information, the FDA reviewer is pointing out Amarex HAS THE DATA! It's "present" in the .xpt files but the FDA reviewer is saying that same data which apparently must be also included in the ADCM is Missing! It hasn't been added!!!
You want to argue Amarex can't include data they don't have? How about explaining why they can't even include data they do have? There is absolutely no excuse for not being able to even copy necessary data over to where proper!!!
All of this brings us back to the top of page 8 which the FDA reviewer uses to preface these deficiencies.
"Of note, the data quality issues described below, which are extensive,.... (and which we just went through ourselves)...may indicate that the process used to collect data from the CRF's WAS FLAWED! If that is the case, additional errors may become apparent during BLA review."
You don't need to understand science to understand what the implications the FDA reviewer is saying.
This is what Amarex submitted based on THEIR data collection and an FDA reviewer has reason to believe THEIR "process used to collect data is flawed".
I guarantee you this is going to also be part of the arbitration!
Part three coming soon... And yes, it gets even worse!"
11
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Aisle Space Is the Real Prize Most cannabis accessory launches arrive dressed up like a gimmick and disappear before anyone has reordered them. J. Harmon has a more sensible target: give women products that look deliberate, work in everyday routines and do not demand designer-level money. The brand is set to debut at MJBizCon 2026 in Las Vegas, with LUVBUDS handling...
Continue Reading
A Partner Megaphone Is Not a Revenue Line Monday's virtual panel gives DarioHealth a useful stage, but investors should not confuse a conference microphone with a signed sales order. Erez Raphael is set to lead a November 23 discussion with Personify Health President Ed Liebowitz at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum, running from noon to 12:50 p.m....
Continue Reading
Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...
Continue Reading
Steam, chatter, and one forgotten burner can turn a holiday meal ugly in a hurry. The Consumer Product Safety Commission’s Nov. 19, 2026 reminder lands on a point that should not need repeating, yet plainly does: Thanksgiving kitchens demand attention, not casual optimism. This is not about ruining anybody’s celebration with a lecture. It is about recognizing that a...
Continue Reading
Employee survey ballots rarely make pulses race, but this one deserves more than a lazy shrug. Prospera Financial Services has landed on The Dallas Morning News’ 2026 Top Workplaces DFW list for a second consecutive year, placing in the Top Small Workplaces category. For a boutique independent broker-dealer, that is not meaningless wall décor. The people doing the...
Continue Reading
Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...
Continue Reading
A $50 carrot on a $350 catering tab tells you exactly where Corner Bakery sees the holiday battlefield: not in one lonely cookie sale, but in the larger group order that can make a restaurant’s day. The chain is pushing holiday catering through November and December, pairing that discount with bakery trays, meals for groups and a promise to handle delivery setup. It is...
Continue Reading
Thirty-eight million dollars landing in one day is no small civic heartbeat. Minnesota’s Give to the Max Day brought in a record $38.4 million in 2026 for nearly 6,000 nonprofits and schools, edging past the $37.8 million raised in 2025. More than 65,000 people gave. That deserves a clear-eyed nod, not a cynical shrug. Still, the number carries two messages at once. It...
Continue Reading
A tax rule most people ignore is getting a television spotlight. 1031 Specialists says it will appear on All Access with Andy Garcia, an educational series distributed to Public Television stations nationwide, to explain the 1031 exchange and its role in real estate investing. That is a sensible bit of exposure for a niche business built around a topic investors tend to...
Continue Reading
A Longer-Term Bet on Household Resilience A bank’s community budget rarely grabs the market by the collar, but TD’s new target deserves more than a polite nod. The bank says it will direct $2 billion, or US$1.4 billion, toward helping people build financial strength across North America over the next decade. That is a sizable commitment, even for an institution with...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of Inducement Grants European Wax Center, Inc. (NASDAQ: EWCZ), known as a leading provider of out-of-home waxing services across the United States, has recently made headlines with its strategic inducement grants. This move comes in light of the recent appointments of key executives, aiming to bolster the company's leadership and operational capabilities....
Continue Reading
Enhancing AI Security Through Strategic Collaboration Check Point Software Technologies Ltd. (NASDAQ: CHKP), a renowned global leader in cyber security solutions, has embarked on an exciting partnership with Microsoft. This collaboration aims to inject enterprise-grade AI security into the Microsoft Copilot Studio, ensuring that organizations can innovate safely and...
Continue Reading
TransMontaigne Partners LLC Enhances Credit Facility Terms TransMontaigne Partners LLC has recently announced a significant development in its financial strategy. The company has officially closed Amendment No. 4 to its existing Credit Agreement, which illustrates its commitment to optimizing financial operations and enhancing financial stability. Understanding the...
Continue Reading
Urgent Appeal for Blood Donations Post-Holiday Season The American Red Cross is currently confronting the threat of a significant blood shortage. As the busy holiday season comes to a close, blood donation rates have plummeted. Unfortunately, the rate at which blood products are being distributed now exceeds the number of donations received, raising concerns about the...
Continue Reading
When weight loss turns hairy, it's not just an old wives' tale. We have some solid evidence from those eggheads at NYU Langone Health, who unearthed this hairy connection between popular weight loss drugs and the glinting domes of the genetically predisposed. Understanding the Hair-Drug Connection The name Ozempic might sound familiar, and not just because it's been...
Continue Reading